Press Releases/IR - Page 1 | TalkMarkets
All Posts > Content under Press Releases/IR
1 to 16 of 417 Posts
1 2 3 ... 27
Acer Therapeutics Announces Pricing Of Underwritten Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, December 13, 2017 12:30 AM EST
The underwritten public offering of 916,667 shares of its common stock is set at a public offering price of $12.00 per share.
In this article: ACER
Read
Churchill Downs Incorporated Announces Proposed Offering Of $300 Million Of Senior Notes Due 2028
Article By: NASDAQ GlobeNewswire
Tuesday, December 12, 2017 9:42 AM EST
Churchill Downs Incorporated, today announced that it intends to offer, subject to market and customary conditions, $300 million in aggregate principal amount of senior notes due 2028 (the “Notes”) in a private offering.
In this article: CHDN
Read
Globalstar Announces Secondary Offering Of Voting Common Stock
Article By: NASDAQ GlobeNewswire
Friday, December 8, 2017 3:39 AM EST
Globalstar, Inc. today announced an offering of 38,000,000 shares of Globalstar’s voting common stock on an underwritten basis by FL Investment Holdings, LLC.
In this article: GSAT
Read
Editas Medicine, Inc., Announces Pricing Of $50 Million Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, December 6, 2017 12:25 PM EST
Editas Medicine, Inc., a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common stock.
In this article: EDIT
Read
Providence Service Corporation Declares Cash Dividend On Convertible Preferred Stock
Article By: NASDAQ GlobeNewswire
Friday, December 1, 2017 11:01 AM EST
The Providence Service Corporation, today announced that its Board of Directors has declared a cash dividend on its 5.5%/8.5% Series A convertible preferred stock.
In this article: PRSC
Read
Cesca Therapeutics Inc. Announces Pricing Of Public Offering Of Up To 900,000 Shares Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, November 29, 2017 1:35 PM EST
Cesca Therapeutics Inc., today announced that it has priced a best efforts registered public offering of up to an aggregate of 900,000 shares of the Company’s common stock at a price to the public of $3.00 per share.
In this article: KOOL
Read
BiondVax Provides Third Quarter 2017 Financial Results And Update
Article By: PR Newswire
Tuesday, November 28, 2017 11:16 AM EST
BiondVax Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced its financial results for the quarter ended September 30, 2017.
In this article: BVXV
Read
First Capital, Inc. Announces Quarterly Dividend
Article By: NASDAQ GlobeNewswire
Friday, November 24, 2017 2:37 PM EST
The Board of Directors of First Capital, Inc. has declared a quarterly cash dividend of $0.22 (twenty-two cents) per share of common stock.
In this article: FCAP
Read
Fentura Financial, Inc. Announces Quarterly Dividend
Article By: NASDAQ GlobeNewswire
Wednesday, November 22, 2017 1:52 PM EST
The Board of Directors of Fentura Financial, Inc. has announced a regular dividend of $0.05 per share for shareholders of record as of November 13, 2017, and payable November 20, 2017.
In this article: FETM
Read
PennantPark Floating Rate Capital Ltd. Prices $138.7 Million 3.83% Notes Offering
Article By: NASDAQ GlobeNewswire
Wednesday, November 22, 2017 11:36 AM EST
PennantPark Floating Rate Capital Ltd. announced that it has priced an institutional offering in Israel of $138.7 million of its 3.83% Series A Notes, or the 2023 Notes.
In this article: PFLT
Read
Oritani Financial Corp. Announces $0.45 Special Dividend
Article By: NASDAQ GlobeNewswire
Tuesday, November 21, 2017 12:33 PM EST
Oritani Financial Corp. announced that its Board of Directors has declared a special cash dividend of $0.45 per share on the company’s common stock.
In this article: ORIT
Read
BiondVax And NIH Sign Clinical Trial Agreement For A Phase 2 Trial In The U.S. With BiondVax's Universal Flu Vaccine
Article By: PR Newswire
Monday, November 20, 2017 1:09 PM EST
BiondVax Pharmaceuticals Ltd. today announced the signing of the clinical trial agreement (CTA) for a Phase 2 clinical trial with the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH).
In this article: BVXV
Read
Medley Management Inc. Declares $0.20 Per Share Dividend And Reports Third Quarter 2017 Results
Article By: NASDAQ GlobeNewswire
Tuesday, November 14, 2017 9:51 AM EST
Medley Management Inc. today reported its financial results for its third quarter ended September 30, 2017.
In this article: MDLY
Read
Canopy Growth Corporation Reports Second Quarter Fiscal 2018 Financial Results
Article By: Technical420
Tuesday, November 14, 2017 7:43 AM EST
Canopy Growth Corporation today released its consolidated financial results for the second quarter ended September 30, 2017.
In this article: TWMJF
Read
Namaste Technologies Adds Another Million In Revenue To The Balance Sheet Through Brazilian Acquisition
Article By: Technical420
Tuesday, November 14, 2017 6:08 AM EST
Namaste Technologies Inc. announced that it has acquired Brazil’s largest vaporizer retailer, vaptvupt.lojaintegrada.com.br, in consideration of signing an exclusive fulfillment agreement for Namaste's Brazilian operations.
In this article: NXTTF
Read
Buckeye Partners, L.P. Prices $400 Million Offering Of Senior Notes
Article By: NASDAQ GlobeNewswire
Thursday, November 9, 2017 5:05 PM EST
Buckeye Partners, L.P. announced today that it has priced an offering of $400 million aggregate principal amount of 4.125% senior unsecured notes due 2027.
In this article: BPL
Read
1 to 16 of 417 Posts
1 2 3 ... 27